Functional Selectivity and Biased Receptor Signaling
Top Cited Papers
Open Access
- 28 October 2010
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 336 (2), 296-302
- https://doi.org/10.1124/jpet.110.173948
Abstract
With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in “one size fits all” assays for detection of agonism. Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways. Thus, such “biased” ligands can produce cell-specific agonism that may require targeted assays to detect and quantify. It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as “pluridimensional efficacy”), leading to a breakdown in the common classifications of agonist and antagonist. This all poses unique challenges to the pharmacologic nomenclature of drugs, the detection and optimization of new drugs, and the association of phenotypic clinical profiles with pharmacological properties of drugs.Keywords
This publication has 66 references indexed in Scilit:
- Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligandsProceedings of the National Academy of Sciences of the United States of America, 2009
- Physiological and pharmacological implications of beta-arrestin regulationPharmacology & Therapeutics, 2009
- The Role of Incretins in Glucose Homeostasis and Diabetes TreatmentPharmacological Reviews, 2008
- Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signallingTrends in Pharmacological Sciences, 2008
- Pharmacological Onomastics: What's in a name?British Journal of Pharmacology, 2008
- Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- GPCR functional selectivity has therapeutic impactTrends in Pharmacological Sciences, 2007
- Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptorsNeuropharmacology, 2007
- β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytesProceedings of the National Academy of Sciences of the United States of America, 2006